Growth Factor Inhibitors: Markets and Opportunities for a Growing Pipeline

    Published: March 1, 2004 | Price: $3,500.00 – $7,000.00

    Growth factors are gene products that play important roles in the regulation of cell division and tissue proliferation. Generally, the binding of a growth factor to its receptor initiates or blocks the ability of cells to divide and multiply. Blood and tissue growth factors have become exciting targets for compounds intended to inhibit or slow the mechanisms involved in their function or growth. This report highlights the research into, and the current and potential key world markets for, products that...
    Growth Factors: Indications, Products, and Markets

    Published: October 1, 2003 | Price: $2,625.00 – $5,250.00

    Growth factors are gene products that play important roles in the regulation of cell division and tissue proliferation. Generally, the binding of a growth factor to its receptor initiates or, in some cases, blocks the ability of cells to divide and multiply. The nature and mode of action of these substances have made them of great interest in various therapeutic areas for which efficacy and specificity must go hand in hand. This report analyzes the world markets for growth factors,...
    H1N1 “Swine Flu” Vaccine Market Review (Revenues, Forecasts, Lessons for Future Pandemic Vaccines)

    Published: May 1, 2010 | Price: $500.00 – $2,400.00

    The H1N1 flu epidemic created a public health emergency in 2009. It also created an opportunity for vaccine manufacturers to demonstrate that working with governments of the US and countries around the world, they could manufacture and distribute a vaccine for the virus strain that may have had an impact in reducing cases and deaths. Who were the companies that performed best in this market? How did goverment contracts play out? Most importantly, what are lessons for future pandemic and...
    H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays)

    Published: May 1, 2009 | Price: $250.00 – $1,600.00

    The outbreak of H1N1 (swine flu) highlighted the public health importance of improved testing techniques and providing market opportunities for manufacturers of diagnostic tests and other products related to the disease. These conclusions and others appear in a new report released from Kalorama Information: Swine Flu Market Alert by Kalorama's lead analyst, Shara Rosen. Regardless of the eventual severity of the epidemic, there will be distinct market impact on both immunoassay and molecular test makers, according to the report. The...
    Handhelds in Healthcare: Markets for Smartphones, iPads and Other Tablet PCs, PDAs, Monitors & Scanners in Medical Applications

    Published: February 1, 2012 | Price: $995.00 – $1,990.00

    A desire to deliver better care and make healthcare workers more productive, as well as the incentives and mandates for EMR usage, has made handhelds ubiquitous in healthcare worldwide. Increasingly healthcare providers are using devices that can provide information and allow them to research, communicate and order services on a mobile basis. This Kalorama Information report - Handhelds in Healthcare- represents Kalorama's second edition of its review of the market for these type of devices. The report focuses on two...
    Handhelds in Healthcare: The World Market for PDAs, Smartphones, Tablet PCs, Handheld Monitors & Scanners

    Published: July 1, 2010 | Price: $3,500.00 – $7,990.00

    This Kalorama Information report - The Global Handheld Healthcare Device Market - focuses on two primary segments of healthcare IT:   Patient Monitoring Devices,   including: Blood pressure devices Pulse oximeters ECG/EKG monitors Ultrasound Diabetes insulin monitors Prothrombin time monitors TENS Fetal heart monitors   Administrative Devices, including: PDA/Smartphones Tablet PCs Inventory/Medication Management Scanners Handheld patient monitoring devices include a wide range of products which provide the benefits of diagnosing, consulting, monitoring and treating patients. Handheld administrative devices include products...
    Healthcare Associated Infection (HAI) Control Markets, Forecasts to 2020: Disinfection, Area, Sterilization, Device Sterilization, Testing-C.diff, Testing-MRSA, Treatments

    Published: May 7, 2014 | Price: $995.00 – $1,990.00

    Healthcare Associated Infection (HAI) Control Markets: Disinfection, Area, Sterilization, Device Sterilization, Testing-C.diff, Testing-MRSA, Treatments Infections from activities and procedures taking place within a healthcare facility have become a cause for great concern. These infection may occur in a postoperative wound or as a complication unrelated to the disease or condition. This report, Healthcare-Associated Infection (HAI) Control Markets: focuses on the market opportunities for companies that can assist hospitals and other healthcare facilities with important HAI mitigation tasks including: preventing, testing...
    Healthcare Computer System Markets and Trends in HIT Buying (Forecasts for System, Service and Support Revenues, Areas of interest, major competitor profiles)

    Published: August 1, 2009 | Price: $1,995.00 – $7,000.00

    The healthcare information technology (HIT) market was in a growth trend prior to the recent recession. While economic times have tightened budgets some, there is still opportunities for companies in this market. In this report, Kalorama takes a comprehensive look at the demand for IT products in the healthcare market - with a focus on computer systems for hospitals, nursing homes, physician offices and other healthcare entities. Kalorama has interviewed experts in the HIT industry and presents the latest findings...
    Healthcare in a Recession (OTC, Generics, Out of Pocket Spending, Healthcare Legislation, Retail Clinics, Outsourcing and Other Topics)

    Published: April 1, 2009 | Price: $500.00 – $3,990.00

    Current economic conditions dominate business strategies. While healthcare has fared better than other industries, it will not be immune from the effects of the current recession. But what aspects of healthcare will be impacted? How much of spending will be out of the consumer's pocket? How will some novel trends (retail clinics, medical tourism) fit into this economy? It is commonly asserted that OTC and generic drugs sales will be boosted. Will this pan out? What will be the possible...
    Healthcare Opportunities for Food Ingredient Manufacturers

    Published: October 1, 2007 | Price: $995.00 – $1,990.00

    For food ingredient companies willing to enter the non-food market, there is over a billion dollars of market potential awaiting them. In addition to increasing the profitability of their traditional product lines, producers of ingredients can potentially expand their markets by moving their products or byproducts into the healthcare sector, where drug producers or manufacturers of some biomedical devices could incorporate them into their products. Kalorama Information's Healthcare Opportunities for Food Ingredient Manufacturers details the sources of ancillary revenue that...
    Healthcare-Associated Infection Testing (HAI) – The “Prevention Effect” on Diagnostic Markets

    Published: September 7, 2017 | Price: $2,400.00 – $4,800.00

    This report takes a look at both prevention procedures such as sterilization and surface area disinfection and testing such as molecular tests and immunoassays.  Infection control in healthcare facilities deals largely with protecting building occupants from patients with communicable infectious diseases. Infections, which may result from activities and procedures taking place within the facility, have become a cause for great concern. Infection that is acquired during the course of healthcare is known as a nosocomial, or hospital acquired, infection. What...
    Hematology and Coagulation Markets (Lab-based and Decentralized Markets)

    Published: May 19, 2020 | Price: $5,000.00 – $10,000.00

    Kalorama Information’s Hematology and Coagulation Markets (Lab-based and Decentralized Markets) examines the current state of two growing testing markets. Hematology is the study of peripheral blood and bone marrow cells in order to diagnose various diseases of the blood including leukemias, anemia and autoimmune diseases. The menu of hematology tests includes: CBC + 5-part differential (or 3-part differential), manual differential/review, hematocrit, hemoglobin (automated, manual), sedimentation rate, reticulocyte count, white blood cell (WBC) count, platelet count and analysis, and red blood...
    Hematology and Coagulation Markets, 2023

    Published: April 6, 2023 | Price: $3,750.00 – $7,000.00

    SKU 23-708: There is a nearly $10 billion-dollar market for hematology and coagulation IVD testing.  Increasingly growth is driven by new technologies, the aging population, and the demand for decentralized testing.   This report provides: Market sizing for Hematology IVD and Coagulation IVD Markets for Decentralized and Lab-based Segments. Forecasts to 2027 Market Share Country Markets for Hematology (Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Spain, Turkey, United Kingdom, United States) Country Markets for Coagulation (Australia, Brazil, Canada, China,...
    Hepatitis Testing Markets

    Published: September 1, 2018 | Price: $2,500.00 – $5,000.00

    Hepatitis Testing Markets This report, Hepatitis Testing Markets, includes Hepatitis Immunoassay Market, 2016 - 2021 Hepatitis Molecular Testing Market, 2016 -2021 Hepatitis Point of Care Markets, 2016-2021 Molecular Testing Market by Type (C, B, A and Others) Key Trends in the Market Geographic Breakout of Market (US, ROW) Company Profiles HCV in particular is a driver of sales in this market. While HCV infections are increasingly caught and treated among baby boomers (a fact easily observable in Medicare billings), U.S....
    Hernia Repair Device Markets and Procedures

    Published: November 1, 2008 | Price: $2,995.00 – $6,995.00

    Hernia repair is a standard part of general surgery, but nonetheless one that has been revolutionized by two events over the past decade and a half: the the development of tension-free and laparoscopic techniques and the use of prosthetic materials. Tension-free mesh-based repairs (eg, Lichtenstein, plug and patch) began to increase in number in the late 1980s. More recently, laparoscopy for general surgery, various laparoscopic techniques have been developed for hernia repair. There has also been revolutionary change in prosthetic...